No one should have to face cancer alone. Each year, 1.8 million people are diagnosed with cancer in the United States. Upon learning this difficult news, individuals also have a minefield of complex information to navigate regarding treatment plans, insurance coverage, clinical trials, and more. Your Cancer Road Map: Navigating Life with Resilience is a compassionate, comprehensive guide for cancer patients, their families, and caregivers, designed to take the guesswork out of these crucial decisions every step of the way. For more than 35 years, the Cancer Support Community (CSC) has been a trusted resource, demystifying the emotional, physical, financial, and logistical challenges related to cancer. From CSC CEO Kim Thiboldeaux, Your Cancer Road Map is a comprehensive guidebook, providing advice and comfort at every point on the cancer journey, from the moment of diagnosis to survivorship and beyond. Your Cancer Road Map covers hard-to-talk-about topics such as treatment options, finances, how cancer can affect your fertility or sexuality, survivor care, hospice care, and end-of-life planning. In the CSC tradition, the book ensures that people impacted by cancer can live their lives to the fullest and enables them to gain a sense of control during what can be an overwhelming and chaotic time. Now more than ever, patients need the tools to participate fully in their healthcare, and communicate their preferences and priorities to their healthcare team so that they can make the best decisions for themselves and their loved ones while living with the highest possible quality of life. Filled with incredible personal stories from people who could be your friends or neighbors, as well as celebrities and influencers, plus workbook pages, checklists, recommended resources, and more, Your Cancer Road Map will be a powerful companion for anyone with questions about cancer.

This book comprehensively summarizes the biology, etiology, and pathology of ovarian cancer and explores the role of deep molecular and cellular profiling in the advancement of precision medicine. The initial chapter discusses our current understanding of the origin, development, progression and tumorigenesis of ovarian cancer. In turn, the book highlights the development of resistance, disease occurrence, and poor prognosis that are the hallmarks of ovarian cancer. The book then reviews the role of deep molecular and cellular profiling to overcome challenges that are associated with the treatment of ovarian cancer. It explores the use of genome-wide association analysis to identify genetic variants for the evaluation of ovarian carcinoma risk and prognostic prediction. Lastly, it highlights various diagnostic and prognostic ovarian cancer biomarkers for the development of molecular-targeted therapy.

This atlas illustrates the latest available data on the cancer epidemic, showing causes, stages of development, and prevalence rates of different types of cancers by gender, income group, and region. It also examines the cost of the disease, both in terms of health care and commercial interests, and the steps being taken to curb the epidemic, from research and screening to cancer management programs and health education.

The preceding decade has seen the production of many cancer at lases. As with other techniques of descriptive epidemiology, these atlases have proved valuable in identifying areas for further re sear~h employing the methods of analytical epidemiology. How ever, the various cancer atlases produceq to date have failed to pro vide a common format of presentation, which has limited their comparability and frustrated in a large measure any attempt to compare risks across national boundaries, boundaries which in terms of environmental exposures may have little meaning. In this volume, many features of cancer atlases are presented and there are discussions on the areas where moves towards standardization could greatly increase the utility of the finished product. In contrast to topographic maps, i. e., representations of natural and man-made features on the surface of the earth, thematic maps concentrate on displaying the geographical occurrence and varia tion of a single phenomenon - the "theme" of the map. The link between thematic and base mapping is rather strong as the themat ic information to be depicted is of greater value if displayed on an accurate base map. Further, the thematic map generally uses statis tical data which are frequently related to internal administrative boundaries for enumeration. The major reason for constructing a thematic map is to discover the spatial structure of the theme of the map and to then relate the structure to some aspects of the under lying environment.

Mohs Micrographic Surgery, an advanced treatment procedure for skin cancer, offers the highest potential for recovery--even if the skin cancer has been previously treated. This procedure is a state-of-the-art treatment in which the physician serves as surgeon, pathologist, and reconstructive surgeon. It relies on the accuracy of a microscope to trace and ensure removal of skin cancer down to its roots. This procedure allows dermatologists trained in Mohs Surgery to see beyond the visible disease and to precisely identify and remove the entire tumor, leaving healthy tissue unharmed. This procedure is most often used in treating two of the most common forms of skin cancer: basal cell carcinoma and squamous cell carcinoma. The cure rate for Mohs Micrographic Surgery is the highest of all treatments for skin cancer--up to 99 percent even if other forms of treatment have failed. This procedure, the most exact and precise method of tumor removal, minimizes the chance of regrowth and lessens the potential for scarring or disfigurement

This book was written both for survivors and health professionals, some of whom are cancer survivors, too. Our goal is to provide you with a survivor's road map. --Dr. Ernest H. Rosenbaum * More than 30 medical professionals reveal insights on surviving cancer to empower cancer survivors and their caregivers, as well as the doctors who manage their continued care. The CDC's National Action Plan for Cancer Survivorship estimates that there are 9.6 million persons living following a cancer diagnosis. And this number is strictly related to patients. It does not include family members, friends, or caregivers. For anyone approaching life from the perspective of remission, respected oncologist Dr. Ernest Rosenbaum leads a team of 34 oncology specialists and medical contributors--some of whom are both doctors and survivors themselves--in creating a guide specifically geared for cancer survivorship. The growing number of people approaching life post-cancer will find solace, understanding, and opportunity with information specifically geared to managing the lingering effects of cancer treatment, such as: * Lifestyle changes to improve health and longevity * What survivors need to know following anticancer therapy * How to manage the side effects of chemotherapy and radiation therapy * How to set goals for the future

The recent advancements in the machine learning paradigm have various applications, specifically in the field of medical data analysis. Research has proven the high accuracy of deep learning algorithms, and they have become a standard choice for analyzing medical data, especially medical images, video, and electronic health records. Deep learning methods applied to electronic health records are contributing to understanding the evolution of chronic diseases and predicting the risk of developing those diseases. Approaches and Applications of Deep Learning in Virtual Medical Care considers the applications of deep learning in virtual medical care and delves into complex deep learning algorithms, calibrates models, and improves the predictions of the trained model on medical imaging. Covering topics such as big data and medical sensors, this critical reference source is ideal for researchers, academicians, practitioners, industry professionals, hospital workers, scholars, instructors, and students.